Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) Evropska unija - danščina - EMA (European Medicines Agency)

adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)

glaxosmithkline biologicals s.a. - splittet influenzavirus, inaktiveret, indeholdende antigen: a / vietnam / 1194/2004 (h5n1) som brugt belastning (nibrg-14) - influenza, human; immunization; disease outbreaks - vacciner - prophylax af influenza i en officielt erklæret pandemisk situation. pandemic influenza vaccine bør anvendes i overensstemmelse med officielle retningslinjer.

COVID-19 Vaccine (inactivated, adjuvanted) Valneva Evropska unija - danščina - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vacciner - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Solifenacinsuccinat/Tamsulosinhydrochlorid "Aristo" 6+0,4 mg tabletter med modificeret udløsning Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

solifenacinsuccinat/tamsulosinhydrochlorid "aristo" 6+0,4 mg tabletter med modificeret udløsning

aristo pharma gmbh - solifenacinsuccinat, tamsulosinhydrochlorid - tabletter med modificeret udløsning - 6+0,4 mg

Solifenacinsuccinat/Tamsulosinhydrochlorid "Heumann" 6+0,4 mg tabletter med modificeret udløsning Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

solifenacinsuccinat/tamsulosinhydrochlorid "heumann" 6+0,4 mg tabletter med modificeret udløsning

heumann pharma gmbh & co. generica kg - solifenacinsuccinat, tamsulosinhydrochlorid - tabletter med modificeret udløsning - 6+0,4 mg